A stretchy, heat-activated skin patch developed by researchers offers a surgery-free treatment for melanoma by using laser-induced graphene filled with copper(II) oxide. Operating as a breathable, chemically inert wearable, the device releases copper ions under low-power laser warming to induce oxidative stress, killing cancer cells and inhibiting metastasis without damaging surrounding healthy tissue.
Engineering the Nanomaterial Architecture
Traditional oncology interventions for cutaneous malignancies often exact a severe physical toll on patients. Melanomas typically form in the outermost and middle layers of the skin. That makes it challenging to kill cancer cells while leaving the surrounding healthy tissue unscathed. Recent advancements in nanotechnology could result in a gentler, more targeted option for skin cancer therapy.
Enter laser-induced graphene, a laser-etched porous carbon material. To design a tailored skin patch for focused melanoma treatment, scientists Xin Li, Shi Chen, Meijia Gu, and Ruquan Ye packed copper(II) oxide into the pores of this substrate and integrated the resulting matrix into an elastic silicone polymer.
On its own, the patch is soft, stretchy, breathable on the skin, and chemically inert. However, the investigators theorized that mild warming of the device would prompt the liberation of copper ions, which would then engage with the DNA of cancer cells and destroy them via oxidative stress. This biochemical pathway should also trigger an immune response that would inhibit tumor cell migration into other parts of the body, a process known as metastasis.
Thermal Activation and Cellular Disruption
Validating the hardware mechanics required controlled laboratory testing on cultured biological samples. To test the concept, the researchers placed the patch over melanoma cells cultured in the laboratory. They warmed the patch to 108 degrees Fahrenheit (42 degrees Celsius) with a low-power laser.
In its now-activated state, the patch released copper ions into the melanoma cells directly beneath it. Upon analysis, the investigators discovered that the copper ions successfully eliminated the majority of the laboratory-grown melanoma cells while simultaneously reducing their motility.
Translating benchtop chemistry into in vivo testing required rigorous animal trials to monitor systemic toxicity and localized efficacy. In a preliminary 10-day animal study, they placed patches on mice with melanoma. On days 1 and 5, the patches were activated with a laser for one hour. The treatment reduced melanoma lesions by 97 percent.
Consistent with their expectations, tissue analysis confirmed that cancer cells remained confined within the tumor boundaries, and there was no buildup of copper ions in the blood or internal organs. Drawing from these preliminary findings alongside the device’s simplicity of use and capacity for multiple applications, the investigators inferred that this innovation might one day facilitate precise, secure, and effective melanoma care for people.
Funding and Institutional Backing
The development and initial validation phases of this wearable oncology platform rely on structured institutional grants and laboratory backing. Financial backing for the project was provided by the National Natural Science Foundation of China, the National Key Research and Development Program of China, and the Shenzhen Key Laboratory of Microbiology in Genomic Modification & Editing and Application, as noted by the study’s creators.
While human clinical trials remain on the future roadmap, the convergence of laser-induced carbon matrices and targeted ion delivery presents a compelling hardware-based alternative to conventional surgical excision in dermatological oncology.
